Changing Pattern of Pediatric Endocrinology Referrals Over Two Decades: A Study From a Tertiary Center in Western

Vaman Khadilkar1, Karishma Bhade1, Sonali Wagle1

  • 1Growth and Pediatric Endocrinology, Hirabai Cowasji Jehangir Medical Research Institute, Pune, IND.

Cureus
|October 2, 2025
PubMed

Insights

Pediatric endocrine referrals doubled over 20 years, with short stature and puberty disorders rising, especially in females. A gap in primary care recognition of endocrine issues persists.

Area of Science:

  • Pediatric Endocrinology
  • Medical Education
  • Healthcare Management

Background:

  • Understanding pediatric endocrinology referral patterns is crucial for optimizing patient care and medical education.
  • Analyzing referral trends helps identify gaps in primary care and informs resource allocation.

Purpose of the Study:

  • To analyze pediatric endocrine referral patterns and reasons for referral over two decades (2002-2003 vs. 2022-2023).
  • To compare referral reasons with final diagnoses and identify discrepancies.

Main Methods:

  • Retrospective analysis of 2595 patient records from a tertiary care hospital in Western India.
  • Referral reasons categorized using the International Classification of Pediatric Endocrinology Diagnoses (ICPED) 2016.

Main Results:

  • Total referrals increased nearly twofold over two decades.
  • Short stature, disorders of puberty, and obesity were the most common referral reasons.
  • Discrepancies between referral reasons and final diagnoses were noted, particularly for micropenis, gynecomastia, and obesity.

Conclusions:

  • Pediatric endocrine referral numbers have significantly increased over 20 years, with shifts in referral demographics.
  • A notable gap exists in primary care clinicians' recognition of pediatric endocrine conditions.
  • Focused medical education and awareness initiatives are needed for primary care providers.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K